
Seagen SGEN
Quarterly report 2023-Q3
added 11-01-2023
Seagen Total Inventories 2011-2026 | SGEN
Annual Total Inventories Seagen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 427 M | 201 M | 116 M | 85.9 M | 53.2 M | 60 M | 68.1 M | 57 M | 43.5 M | 27.1 M | - | 9.47 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 427 M | 9.47 M | 104 M |
Quarterly Total Inventories Seagen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 531 M | 487 M | 478 M | 427 M | 365 M | - | 276 M | 201 M | 181 M | 163 M | 147 M | 116 M | 116 M | 116 M | 116 M | 85.9 M | 85.9 M | 85.9 M | 85.9 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 60 M | 60 M | 60 M | 60 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | 57 M | 57 M | 57 M | 57 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 37.7 M | 37.7 M | 25.7 M | 15.8 M | 9.47 M | 3.43 M | - | 9.47 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 531 M | 3.43 M | 111 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.88 | - | $ 6.47 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.67 | - | $ 3.76 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Innoviva
INVA
|
39.2 M | $ 23.69 | - | $ 1.6 B | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.09 | - | $ 437 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.29 | - | $ 2.96 B | ||
|
Jaguar Health
JAGX
|
8.6 M | $ 0.24 | - | $ 560 K | ||
|
KalVista Pharmaceuticals
KALV
|
3.43 M | $ 19.24 | - | $ 1.04 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.48 | - | $ 394 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |